Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nordic Mining ASA (EN Expand:NOM): Interim report per 31 March 2024

Please find enclosed Nordic Mining’s interim report and company presentation for the first quarter of 2024. The interim report and company update will be presented digitally today, Tuesday 7 May 2024 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/landingpage/hegnarmedia/20240507_4/ Summary of important events in the first quarter of 2024: ·The Company reported NOK 543.2 million

poLight ASA: Last day of the Subscription Period in the Rights Issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.Reference is made to previous stock exchange announcements from poLight ASA ("poLight" or the "Company") regarding the Company's partially underwritten rights issue of minimum 56,313,623 new shares and maximum 69,305,075 new shares (the "Offer Shares"), to raise gross proceeds of up to NOK

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

Press Release – Oslo, Norway, May 7, 2024: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces its participation in the congress, and two abstract presentations at the AUA 2024: the American Urological Association Annual Congress 2024 was held May 3-6, 2024, in San Antonio, TX, USA. The results of the BRAVO study performed within the VA healthcare system showed significant decreases in the risk of recurrence and progression, as well as the potential for improved overall survival in patients who received a blue light cystoscopy (BLC[®]) compared to patients whose cystoscopy was

Moberg Pharma´s interim report January - March 2024

LAUNCH INITIATED IN SWEDENFIRST QUARTER (JAN-MAR 2024) · Net revenue SEK 0.8 million (0) · EBITDA SEK -7.6 million (-6.1) · Operating profit (EBIT) SEK -7.9 million (-6.7) · Profit after tax SEK -6.5 million (-5.0) · Diluted earnings per share SEK -0.23 (-0.51) · Cash and cash equivalents amounted to 38.6 million (84.5) SIGNIFICANT EVENTS IN THE FIRST QUARTER · The sale of MOB-015 in Sweden under the brand name Terclara® has begun in collaboration with the company’s partner Allderma and the majority of pharmacies around the country have decided to sell the

Notice of the extra general meeting in Misen Energy AB (publ)

The shareholders of Misen Energy AB (publ), reg. no. 556526-3968, (the “Company”) are hereby invited to the extra general meeting to be held on Tuesday, 28 May 2024 at 9 a.m. at Baker McKenzie's office at Vasagatan 7 in Stockholm. Right to attend the extra general meeting Shareholders who wish to participate in the general meeting must: i. on the record date, which is Monday 20 May 2024, be registered in the share register maintained by Euroclear Sweden AB; andii. no later than on Wednesday 22 May 2024 notify the Company of their and any counsel's participation at the general

Optomed Plc: Interim Report, January – March 2024

Optomed Plc Stock Exchange Release 7 May 2024 at 9.00, Helsinki   Optomed Plc: Interim Report, January – March 2024   January – March 2024   · Revenue decreased by 4.4 percent to EUR 3.3 (3.5) million. · Devices segment revenue increased by 0.1 percent to EUR 0.9 (0.9) million. · Software segment revenue decreased by 5.9 percent to EUR 2.4 (2.6) million. · EBITDA and adjusted EBITDA amounted to EUR -0.6 (-0.5) million corresponding to -26.3 (-14.8) percent of revenue. · Outlook unchanged: Optomed expects its full year 2024 revenue to grow compared to 2023.

Outokumpu interim report January–March 2024: Gradual market recovery in Europe continued, while the political strike in Finland burdened results

Outokumpu CorporationInterim reportMay 7, 2024 at 9.00 am EESTHighlights in Q1 2024 •        Stainless steel deliveries were 444,000 tonnes (505,000 tonnes)*. •        Adjusted EBITDA amounted to EUR 38 million (EUR 204 million). •        EBITDA was EUR 37 million (EUR 198 million). •        ROCE amounted to -5.7% (18.4%). •        Free cash flow was EUR -26 million (EUR 160 million incl. discontinued operations). •        Earnings per share was EUR -0.05 (EUR 0.22). •        The most recent share buyback program was completed on February 29, 2024, and during the

Raute Corporation - Manager's transactions - Saariaho Mika

Raute Corporation, Manager’s transactions, May 7, 2024, at 9:00 a.m. Raute Corporation – Manager’s transactions – Saariaho Mika ____________________________________________ Person subject to the notification requirement Name: Saariaho, Mika Petteri Position: Chief Executive Officer Issuer: Raute Oyj LEI: 743700G00629V99PE435 Notification type: INITIAL NOTIFICATION Reference number: 61803/5/4 ____________________________________________ Transaction date: 2024-05-06 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009004741 Nature

Childhood sedentariness linked to premature heart damage – light physical activity reversed the risk

An increase in sedentary time from childhood caused progressing heart enlargement, a new study shows. However, light physical activity could reduce the risk. The study was conducted in collaboration between the Universities of Bristol and Exeter, and the University of Eastern Finland, and the results were published in the prestigious European Journal of Preventive Cardiology.Left ventricular hypetrophy refers to an excessive increase in heart mass and size. In adults, it is known to increase the risk for heart attacks, stroke, and premature death. In the present study, 1,682 children

Outokumpu increases its EBITDA run-rate improvement target by EUR 150 million to further strengthen its competitiveness

Outokumpu CorporationStock exchange releaseMay 7, 2024 at 8.55 am EESTOutokumpu increases its EBITDA run-rate improvement target by EUR 150 million to further strengthen its competitiveness Outokumpu has made strong progress with the execution of the second phase of its strategy and reached its EBITDA run-rate improvement target ahead of schedule. At the end of the first quarter of 2024, Outokumpu had cumulatively improved its EBITDA run-rate by EUR 233 million since the start of the second phase, which will last until the end of 2025. To emphasize the company’s strong focus on

Crayon reports strong gross profit growth in Q1

Crayon Group Holding ASA (OSE: CRAYN) today reported its first-quarter results with a Gross Profit growth of 17% and Adjusted EBITDA at NOK 203m, corresponding to a margin of 14%."We have delivered a strong start to the year, demonstrating how Crayon’s unique capabilities are well-aligned with the market’s rising demand for software and cloud,” said CEO Melissa Mulholland. “As businesses expand their IT portfolio to prepare for generative AI, more companies need software for security and productivity requirements. This, coupled with our global market reach, means we continue to see

HydrogenPro ASA – Q1 2024 Webcast details

Oslo, 7 May 2024 - Following the release of Q1 2024 figures earlier this morning, HydrogenPro ASA (OSE: HYPRO) will host a webcast presentation of the results at 10:00 am CET, followed by a Q&A session. Questions can be posted online during the presentation. The presentation will be held by Jarle Dragvik (CEO), Martin Thanem Holtet (CFO) and Odd-Arne Lorentsen (CTO). Link to webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20240507_3/

Atrium Ljungberg rents out 10,000 m[2] in Hagastaden

Atrium Ljungberg has signed a lease contract with the Swedish Economic Crime Authority, which is moving to PV-palatset in Hagastaden. The contract covers a total of 10,000 m[2]. The once-industrial PV-palatset is currently undergoing extensive renovation, and the authority is planning to move in at the end of 2025.The Swedish Economic Crime Authority is a Swedish authority that fights and prevents economic crime. Today, the authority has offices on Kungsholmen, and in December 2025 it will move its head office and Stockholm operations to Atrium Ljungberg’s property PV-palatset in Hagastaden.

Anora Group Plc’s Interim report for 1 January - 31 March 2024

Anora Group Plc   Interim report  7 May 2024 at 8:30 am EEST Anora Group Plc’s Interim report for 1 January - 31 March 2024 Comparable EBITDA improved in Q1 due to higher gross margin and cost reduction This release is a summary of Anora Group Plc's Interim report January-March 2024. The complete report is attached to this release and is also available on the company website at: www.anora.com/en/investors Q1 2024 in brief · Net sales were EUR 146.9 (159.5) million, down by 7.9%. · Comparable EBITDA was EUR 8.9 (7.9) million, or 6.1% (5.0%) of net sales, up by 12.1%. ·

Interim report, January–March 2024

January–March 2024 · Net sales decreased by 2 percent to SEK 6,792m (6,927). · Gross profit increased by 2 percent to SEK 2,312m (2,260). · EBITDA rose by 11 percent to SEK 768m (692). · Adjusted EBITDA[1] decreased by 5 percent to SEK 794m (834). · The loss after tax for the quarter was SEK -90m (-78). · Basic earnings per share were SEK -0.11 (-0.09) and diluted earnings per share were SEK -0.11 (-0.09). · Cash flow from operating activities was SEK 553m (212). “Reigniting our growth with improved profitability is the key objective of the transformation work

HANZA: Interim report January–March 2024

HANZA reports a slowdown in the economy, which has been responded to with an efficiency program. This, combined with a recently completed acquisition and new sales activities, means that both growth and margins are expected to increase. The Board decided in the quarter to increase the financial targets for 2025. At the same time, HANZA's strong financial position opens up for opportunities for further acquisitions.First quarter 2024 · Net sales increased by 18% to SEK 1,253 million (1,065).Adjusted for acquisitions and currency, net sales decreased by 6%. · Operating profit

Improved earnings and robust profitability with increased investments

Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is proud to report an increase in net sales with 10% to SEK 427.2 million (387.1) and earning per share increased with 27 per cent to SEK 0.38 (0.30). EBITDA increased with 1% to SEK 151,0 million (150,0) and the EBITDA margin was 35.4% (38.8%) in the first quarter.“Truecaller continued to grow strongly in the first quarter. We added more than nine million monthly and daily active users, and on average the number of monthly users was 383 million. Conversion of paying users continued to

Archer Limited: Continued strong financial performance in first quarter

Hamilton Bermuda (May 7th, 2024) First Quarter 2024 Highlights: · Revenue of $308 million, up 16% YOY · Adjusted EBITDA of $32.9 million, up 20% YOY · EBITDA of $30.9 million, up 23% YOY · Cash contribution of $21.8 million, up 39% YOY · Grew backlog by 80% during the quarter, from USD 1.5 bn to 2.5 bn · Improved adjusted net income in Q1 of $2.6 million compared to Q1 2023 · Leverage ratio reduced to 2.8 from 2.9 at year-end · Completed the acquisition of 65% of the shares in Vertikal Service AS · Executed share consolidation CEO Dag Skindlo comments: “

Raisio plc’s Interim Report January-March 2024

Raisio Plc’s Interim Report, May 7th, 2024 at 8.30 a.m. Finnish timeNet sales and profitability at the level of the comparison period, cash flow continued to strengthen FINANCIAL DEVELOPMENT IN BRIEF JANUARY–MARCH 2024, CONTINUING OPERATIONS • The Group’s net sales totalled EUR 55.5 (56.5) million, which signified a decrease of 1.7%.• Comparable EBITDA was EUR 6.8 (6.7) million, which accounted for 12.3 (11.9) per cent of net sales.• EBITDA was EUR 6.1* (6.5*) million, which accounted for 11.0 (11.5) per cent of net sales.• Comparable EBIT was EUR 4.2 (4.2) million,

60,000 companies have not filed their beneficial owner details – may now risk deregistration

The Finnish Patent and Registration Office (PRH), which maintains the Finnish Trade Register, will deregister companies that have not filed their beneficial owner details despite requests to do so.This week, the PRH sent reminder letters to thousands of limited liability companies and co-operatives that have not filed their beneficial owner details. The PRH may deregister these companies if they – despite reminders – do not file their beneficial owner details by the deadline. According to the Finnish Trade Register Act, all limited liability companies and co-operatives must file details

BlueNord Announce First Quarter 2024 Results

Oslo, 7 May 2024: BlueNord ASA ("BlueNord" or the "Company") today published its first quarter of 2024 results. During the quarter, the Company delivered strong operational and financial performance. In addition, first gas from Tyra II was successfully achieved which means the project has entered a new phase of ramp-up where plateau production is expected in Q4 of 2024. Highlights: · First quarter net hydrocarbon production of 23.5 mboepd, above quarterly guidance of 22.0-23.0 moepd, with the first Halfdan Tor NE infill well commencing production on 26 March with an initial

Breakthrough paves the way for next generation of vision implants

A group of researchers from Chalmers University of Technology in Sweden, University of Freiburg and the Netherlands Institute for Neuroscience have created an exceptionally small implant, with electrodes the size of a single neuron that can also remain intact in the body over time – a unique combination that holds promise for future vision implants for the blind. Often when a person is blind, some or part of the eye is damaged, but the visual cortex in the brain is still functioning and waiting for input. When considering brain stimulation for sight restoration, there needs to

Interim report Q1 2024

“The first quarter of the year was in line with our expectations considering the overall weaker demand and a more typical seasonality compared to the first quarter 2023. Given the uncertain market situation it is positive that we managed to improve the margin sequentially from the fourth quarter. Our companies’ initiatives to strengthen profitability is already having some effect, and this will be more noticeable once the economic climate improves", says Christer Hansson, interim CEO of Storskogen.First quarter (1 January - 31 March 2024) · Net sales decreased by 9 percent to SEK 8,358

HydrogenPro ASA - First quarter 2024 results

7 May 2024 - HydrogenPro ASA (OSE: HYPRO): HydrogenPro has today reported its financial results for the first quarter. Achievements and highlights:   · Secured strategic NOK 82.7m investment from Andritz   · New board elected, chaired by Dag J. Opedal   · Cash balance of NOK 185 mill per 31 March 2024 (increased by NOK 24 mill during the quarter)   · On-going preparations on Salzgitter project - planned completion of manufacturing by Q3 2024   · Awarded compensated 300 MW FEED study in Texas, USA   · On-going feasibility study of expansion of electrode manufacturing

There are no items matching the current filter
There are no more items matching the current filter
Back to top